{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:56:04Z","timestamp":1772726164232,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,6]]},"DOI":"10.7759\/cureus.66257","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T09:07:03Z","timestamp":1722935223000},"source":"Crossref","is-referenced-by-count":2,"title":["Incidence of Non-alcoholic Fatty Liver Disease (NAFLD)\/Non-alcoholic Steatohepatitis (NASH) in the Female Population of North Karnataka: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Geeta S","family":"Desai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Hajare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandesha","family":"Ghorpade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2022.11.014","article-title":"Indian National Association for Study of the Liver (INASL) guidance paper on nomenclature, diagnosis and treatment of nonalcoholic fatty liver disease (NAFLD)","volume":"13","author":"Duseja A","year":"2023","unstructured":"Duseja A, Singh SP, De A, et al.. Indian National Association for Study of the Liver (INASL) guidance paper on nomenclature, diagnosis and treatment of nonalcoholic fatty liver disease (NAFLD). J Clin Exp Hepatol. 2023, 13:273-302. 10.1016\/j.jceh.2022.11.014","journal-title":"J Clin Exp Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13040614","article-title":"The link between NAFLD and metabolic syndrome","volume":"13","author":"Radu F","year":"2023","unstructured":"Radu F, Potcovaru CG, Salmen T, Filip PV, Pop C, Fierbin\u021beanu-Braticievici C. The link between NAFLD and metabolic syndrome. Diagnostics (Basel). 2023, 13:10.3390\/diagnostics13040614","journal-title":"Diagnostics (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33977","article-title":"Prevalence, metabolic profile, and associated risk factors of non-alcoholic fatty liver disease in an adult population of India","volume":"15","author":"Singhai A","year":"2023","unstructured":"Singhai A, Yadav V, Joshi R, Malik R, Savitha BT, Kamle S. Prevalence, metabolic profile, and associated risk factors of non-alcoholic fatty liver disease in an adult population of India. Cureus. 2023, 15:e33977. 10.7759\/cureus.33977","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2023.100220","article-title":"Prevalence and associated factors for non-alcoholic fatty liver\u00a0disease among adults in the South Asian Region: a meta-analysis","volume":"15","author":"Niriella MA","year":"2023","unstructured":"Niriella MA, Ediriweera DS, Withanage MY, Darshika S, De Silva ST, Janaka de Silva H. Prevalence and associated factors for non-alcoholic fatty liver\u00a0disease among adults in the South Asian Region: a meta-analysis. Lancet Reg Health Southeast Asia. 2023, 15:100220. 10.1016\/j.lansea.2023.100220","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/jehp.jehp_208_23","article-title":"Evaluation of risk factors for non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Kannan S","year":"2023","unstructured":"Kannan S, Nelliyanil M, Mendagudli R, et al.. Evaluation of risk factors for non-alcoholic fatty liver disease in India: a systematic review and meta-analysis. J Educ Health Promot. 2023, 12:435. 10.4103\/jehp.jehp_208_23","journal-title":"J Educ Health Promot"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.deman.2023.100161","article-title":"Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients from the eastern region of India","volume":"12","author":"Sinha A","year":"2023","unstructured":"Sinha A, Bankura B. Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients from the eastern region of India. Diabet Epidemiol Manag. 2023, 12:100161. 10.1016\/j.deman.2023.100161","journal-title":"Diabet Epidemiol Manag"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","unstructured":"Shalimar, Elhence A, Bansal B, Gupta H, Anand A, Singh TP, Goel A. Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis. J Clin Exp Hepatol. 2022, 12:818-29. 10.1016\/j.jceh.2021.11.010","journal-title":"J Clin Exp Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260320","article-title":"Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)","volume":"16","author":"Eskridge W","year":"2021","unstructured":"Eskridge W, Vierling JM, Gosbee W, Wan GA, Hyunh ML, Chang HE. Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE). PLoS One. 2021, 16:e0260320. 10.1371\/journal.pone.0260320","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al.. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023, 77:1797-835. 10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","unstructured":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021, 75.659-89. 10.1016\/j.jhep.2021.05.025","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-019-00991-2","article-title":"Body mass index-based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease","volume":"39","author":"Shalimar","year":"2020","unstructured":"Shalimar, Kumar R, Rout G, et al.. Body mass index-based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease. Indian J Gastroenterol. 2020, 39:32-41. 10.1007\/s12664-019-00991-2","journal-title":"Indian J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10018-1067","article-title":"Transient elastography (Fibroscan\u00ae): a new look of liver fibrosis and beyond","volume":"3","author":"Wong GL","year":"2013","unstructured":"Wong GL. Transient elastography (Fibroscan\u00ae): a new look of liver fibrosis and beyond. Euroasian J Hepato-Gastroenterol. 2013, 3:70-7. 10.5005\/jp-journals-10018-1067","journal-title":"Euroasian J Hepato-Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/ijcm.ijcm_437_22","article-title":"Prevalence of non-alcoholic fatty liver disease in urban adult population in a tertiary care center, Chennai","volume":"48","author":"Anton MC","year":"2023","unstructured":"Anton MC, Shanthi B, Sridevi C. Prevalence of non-alcoholic fatty liver disease in urban adult population in a tertiary care center, Chennai. Indian J Community Med. 2023, 48:601-4. 10.4103\/ijcm.ijcm_437_22","journal-title":"Indian J Community Med"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1016\/S1665-2681(19)31922-2","article-title":"Prevalence of non-alcoholic fatty liver disease: population based study","volume":"6","author":"Amarapurkar D","year":"2007","unstructured":"Amarapurkar D, Kamani P, Patel N, et al.. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007, 6:161-3.","journal-title":"Ann Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0019-557X.177295","article-title":"Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India","volume":"60","author":"Majumdar A","year":"2016","unstructured":"Majumdar A, Misra P, Sharma S, Kant S, Krishnan A, Pandav CS. Prevalence of nonalcoholic fatty liver disease in an adult population in a rural community of Haryana, India. Indian J Public Health. 2016, 60:26-33. 10.4103\/0019-557X.177295","journal-title":"Indian J Public Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53947-z","article-title":"The impact of NAFLD and waist circumference changes on diabetes development in prediabetes subjects","volume":"9","author":"Lee J","year":"2019","unstructured":"Lee J, Cho YK, Kang YM, et al.. The impact of NAFLD and waist circumference changes on diabetes development in prediabetes subjects. Sci Rep. 2019, 9:17258. 10.1038\/s41598-019-53947-z","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076388","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study","volume":"384","author":"Kim KS","year":"2024","unstructured":"Kim KS, Hong S, Han K, Park CY. Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study. BMJ. 2024, 384:e076388. 10.1136\/bmj-2023-076388","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00157-7","article-title":"Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis","volume":"8","author":"Huang DQ","year":"2023","unstructured":"Huang DQ, Noureddin N, Ajmera V, et al.. Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis. Lancet Gastroenterol Hepatol. 2023, 8:829-36. 10.1016\/S2468-1253(23)00157-7","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref19","article-title":"Fibroscan versus simple noninvasive screening tools in predicting fibrosis in high-risk nonalcoholic fatty liver disease patients from Western India","volume":"28","author":"Pathik P","year":"2015","unstructured":"Pathik P, Ravindra S, Ajay C, Prasad B, Jatin P, Prabha S. Fibroscan versus simple noninvasive screening tools in predicting fibrosis in high-risk nonalcoholic fatty liver disease patients from Western India. Ann Gastroenterol. 2015, 28:281-6.","journal-title":"Ann Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.58414\/SCIENTIFICTEMPER.2023.14.4.08","article-title":"Prevalence of non-alcoholic steatohepatitis in a general population of North Karnataka","volume":"14","author":"Desai GS","year":"2023","unstructured":"Desai GS, Hajare S, Kharde S. Prevalence of non-alcoholic steatohepatitis in a general population of North Karnataka. Sci Temper. 2023, 14:1106-12. 10.58414\/SCIENTIFICTEMPER.2023.14.4.08","journal-title":"Sci Temper"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong VW","year":"2010","unstructured":"Wong VW, Vergniol J, Wong GL, et al.. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010, 51:454-62. 10.1002\/hep.23312","journal-title":"Hepatology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275113-incidence-of-non-alcoholic-fatty-liver-disease-nafldnon-alcoholic-steatohepatitis-nash-in-the-female-population-of-north-karnataka-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T09:07:08Z","timestamp":1722935228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275113-incidence-of-non-alcoholic-fatty-liver-disease-nafldnon-alcoholic-steatohepatitis-nash-in-the-female-population-of-north-karnataka-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.66257","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}